Chronic urticaria (CU) is a debilitating skin disease affecting around 1% of the population.
CU can be subdivided into chronic spontaneous urticaria (CSU) and chronic inducible …

Biomarkers that are able to predict the response to omalizumab (OMA) in chronic
spontaneous urticaria (CSU) are highly valued. The aim of our study was to evaluate the …

Background Chronic spontaneous urticaria (CSU) is common, chronic, and debilitating, and
has serious effects on quality of life and mental health. Three of 4 patients with CSU are …

To the Editor, Chronic spontaneous urticaria (CSU) is a frequent disorder that is strongly
associated with autoimmunity. 1 This is supported by high rates of autoimmune …

Omalizumab has high treatment efficacy in patients with chronic spontaneous urticaria
(CSU) who do not respond to high doses of antihistamines. Systemic immune‐inflammation …

Background Fatigue is a common and disabling symptom in chronic inflammatory diseases.
To the best of our knowledge, there are no studies evaluating fatigue thoroughly in patients …

Mast cells and eosinophils are considered pivotal contributors to the pathogenesis of
chronic spontaneous urticaria (CSU). However, emerging evidence suggests that …

Background: Endothelin-1 (ET-1) and interleukin-33 (IL-33) can modulate the activation of
mast cells and basophils in the pathophysiology of allergic diseases, interplaying with other …

Introduction: This study aimed to evaluate factors affecting drug survival and treatment
response in patients with chronic urticaria treated with omalizumab in clinical practice …

Purpose: The aim of this study was to evaluate the effect of omalizumab on
immunoinflammatory cells in patients with chronic spontaneous urticaria (CSU). Material …